Leukaemia cutis: clinical manifestation of chronic lymphocytic leukaemia relapse.
Keywords:
leukaemia cutis, B-cell chronic lymphocytic leukaemia, clorambucile, sistemic steroidsAbstract
We present a 71 year old male patlent with prevlous records of Chronic Lymphocytic Leukaemia who presented with a tumoral skin lesion. Histological and immunohistochemical studies confirmed the Leukaemia Cutis diagnosis. The patientunderwent treatment with clorambucile and sistemic steroids with remision of both haemathological and skin manifestation. The patient is still under close clinical follow up and remission continues eight months so far.
Downloads
References
Watson KM, Mufti G. Salisbury JR, du Vivier AW, Creamer D. Spectrum of clinical presentation, treatrnent and prognosis In a series of elght patients wlth leukaemia cutis. Clin Exp Dermatol. 2006 Mar; 31(2):218-21.
Longacre T, Smoller B. Leucemia Cutis. Analysis of 50 biopsy-proven cases whit an emphasls oil occurrence in myelodysplastic syndromes. Am J Clin Pathol 1993;100:276- 84.
Miranda ME Olivares L, Rodríguez Tolosa M; Anaya J. Leucemia Cutis. Presentación de un caso y revisión de la literatura. Dermatol Argent 2006; 12(4): 272-275.
Blázquez N, Frnandez Canedo 1. Leucemia Cutánea. Piel 2002; 17:310-315.
Blázquez N, Fernandez Canedo 1, Cardeñoso E, Morán M, Unamrnio E Antúnez E Martín Pascual A. Leucemia cutánea aleucémica: presentación de un caso. Actas Dermosiflhiog. 2002; 93(7):451-456.
Paydas S, Zorludemir S. Leukaemia Cutis and Leukaemlc vasculitis. Br J Dermatol 2000:143:773-779.
Weedon D, Strutton G. Infiltrados cutáneos linfoides y leucémicos. Piel Patología. Editorial Marbán. Madrid. España. Año 2002. Pág 897-930.
Robak E, Robak T, Biernat W, Bartkowlak J; Krykowskl E. Successfiil treatment of leukaemia cutis wth cladribine tu a patient wlth B- ceil chronic lymphocitic leukaemia.
Ratnam KV, Khor CJ, Su WP . Leukemia Cutis. Dermatol Clin. 1994 Apr; 12(2): 419-31
Downloads
Published
How to Cite
Issue
Section
License
The Faculty of Medical Sciences Journal (RFCM) subscribes to the Open Access policy and does not charge authors fees for publishing, nor does it charge readers fees for accessing published articles (APC).